Glutathione (GSH) represents the most abundant and the main antioxidant in the body with important functions in the brain related to Alzheimer's disease (AD).
Recent Advances:
Oxidative stress is one of the central mechanisms in AD. We and others have demonstrated the alteration of GSH levels in the AD brain, its important role in the detoxification of advanced glycation end-products and of acrolein, a by-product of lipid peroxidation. Recent in vivo studies found a decrease of GSH in several areas of the brain from control, mild cognitive impairment, and AD subjects, which are correlated with cognitive decline.
Critical Issues:
Several strategies were developed to restore its intracellular level with the l-cysteine prodrugs or the oral administration of γ-glutamylcysteine to prevent alterations observed in AD. To date, no benefit on GSH level or on oxidative biomarkers has been reported in clinical trials. Thus, it remains uncertain if GSH could be considered a potential preventive or therapeutic approach or a biomarker for AD.
Future Directions:
We address how GSH-coupled nanocarriers represent a promising approach for the functionalization of nanocarriers to overcome the blood/brain barrier (BBB) for the brain delivery of GSH while avoiding cellular toxicity. It is also important to address the presence of GSH in exosomes for its potential intercellular transfer or its shuttle across the BBB under certain conditions. Antioxid. Redox Signal. 35, 270–292.
Get full access to this article
View all access options for this article.
References
1.
AbdalkaderM, LampinenR, KanninenKM, MalmTM, and LiddellJR. Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front Neurosci, 12: 466, 2018.
AgrawalM, Ajazuddin, TripathiDK, SarafS, SarafS, AntimisiarisSG, MourtasS, Hammarlund-UdenaesM, and AlexanderA. Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease. J Control Release, 260: 61–77, 2017.
4.
Ahlgren-BeckendorfJA, ReisingAM, SchanderMA, HerdlerJW, and JohnsonJA. Coordinate regulation of NAD(P)H:quinone oxidoreductase and glutathione-S-transferases in primary cultures of rat neurons and glia: role of the antioxidant/electrophile responsive element. Glia, 25: 131–142, 1999.
5.
AkerboomTP, BilzerM, and SiesH. Competition between transport of glutathione disulfide (GSSG) and glutathione S-conjugates from perfused rat liver into bile. FEBS Lett, 140: 73–76, 1982.
6.
AkerboomTP, BilzerM, and SiesH. The relationship of biliary glutathione disulfide efflux and intracellular glutathione disulfide content in perfused rat liver. J Biol Chem, 257: 4248–4252, 1982.
7.
AkkayaC, YavuzerSS, YavuzerH, ErkolG, BozluolcayM, and DincerY. DNA damage, DNA susceptibility to oxidation and glutathione redox status in patients with Alzheimer's disease treated with and without memantine. J Neurol Sci, 378: 158–162, 2017.
8.
AkterinS, CowburnRF, Miranda-VizueteA, JimenezA, BogdanovicN, WinbladB, and Cedazo-MinguezA. Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease. Cell Death Differ, 13: 1454–1465, 2006.
9.
AllenJ and BradleyRD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med, 17: 827–833, 2011.
10.
Alvarez-SabinJ, DelgadoP, AbilleiraS, MolinaCA, ArenillasJ, RiboM, SantamarinaE, QuintanaM, MonasterioJ, and MontanerJ. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke, 35: 1316–1322, 2004.
AnsariMA and ScheffSW. Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol, 69: 155–167, 2010.
13.
ArodinL, LamparterH, KarlssonH, NennesmoI, BjornstedtM, SchroderJ, and FernandesAP. Alteration of thioredoxin and glutaredoxin in the progression of Alzheimer's disease. J Alzheimers Dis, 39: 787–797, 2014.
14.
ArrigoAP.Gene expression and the thiol redox state. Free Radic Biol Med, 27: 936–944, 1999.
15.
BackosDS, FritzKS, RoedeJR, PetersenDR, FranklinCC. Posttranslational modification and regulation of glutamate-cysteine ligase by the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal. Free Radic Biol Med, 50: 14–26, 2011.
16.
BalazsL and LeonM. Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem Res, 19: 1131–1137, 1994.
17.
BallatoriN, HammondCL, CunninghamJB, KranceSM, and MarchanR. Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins. Toxicol Appl Pharmacol, 204: 238–255, 2005.
18.
BannaiS.Transport of cystine and cysteine in mammalian cells. Biochim Biophys Acta, 779: 289–306, 1984.
19.
BannaiS.Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem, 261: 2256–2263, 1986.
20.
BannaiS, TsukedaH, and OkumuraH. Effect of antioxidants on cultured human diploid fibroblasts exposed to cystine-free medium. Biochem Biophys Res Commun, 74: 1582–1588, 1977.
21.
BaxterPS, BellKF, HaselP, KaindlAM, FrickerM, ThomsonD, CreganSP, GillingwaterTH, and HardinghamGE. Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system. Nat Commun, 6: 6761, 2015.
22.
BeeriMS, MoshierE, SchmeidlerJ, GodboldJ, UribarriJ, ReddyS, SanoM, GrossmanHT, CaiW, VlassaraH, and SilvermanJM. Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mech Ageing Dev, 132: 583–587, 2011.
23.
BelkacemiA and RamassamyC. Time sequence of oxidative stress in the brain from transgenic mice models of Alzheimer's disease related to the amyloid-ß cascade. Free Radic Biol Med, 52: 593–600, 2012.
24.
BellKF, Al-MubarakB, MartelMA, McKayS, WheelanN, HaselP, MarkusNM, BaxterP, DeightonRF, SerioA, BilicanB, ChowdhryS, MeakinPJ, AshfordML, WyllieDJ, ScannevinRH, ChandranS, HayesJD, and HardinghamGE. Neuronal development is promoted by weakened intrinsic antioxidant defences due to epigenetic repression of Nrf2. Nat Commun, 6: 7066, 2015.
25.
BermejoP, Martin-AragonS, BenediJ, SusinC, FeliciE, GilP, RiberaJM, and VillarAM. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from mild cognitive impairment. Free Radic Res, 42: 162–170, 2008.
26.
BiglK, GaunitzF, SchmittA, RothemundS, SchliebsR, MunchG, and ArendtT. Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. J Neural Transm (Vienna), 115: 1545–1556, 2008.
27.
BirkenmeierG, StegemannC, HoffmannR, GuntherR, HuseK, and BirkemeyerC. Posttranslational modification of human glyoxalase 1 indicates redox-dependent regulation. PLoS One, 5: e10399, 2010.
28.
BrancoV, CoppoL, SolaS, LuJ, RodriguesCMP, HolmgrenA, and CarvalhoC. Impaired cross-talk between the thioredoxin and glutathione systems is related to ASK-1 mediated apoptosis in neuronal cells exposed to mercury. Redox Biol, 13: 278–287, 2017.
29.
ButterfieldDA and HalliwellB. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci, 20: 148–160, 2019.
30.
CaiC, DaiX, ZhuY, LianM, XiaoF, DongF, ZhangQ, HuangY, and ZhengQ. A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid beta peptide-mediated neuronal disorder. Appl Microbiol Biotechnol, 100: 825–835, 2016.
31.
CalabreseG, MorganB, and RiemerJ. Mitochondrial glutathione: regulation and functions. Antioxid Redox Signal, 27: 1162–1177, 2017.
32.
CalabreseV, CorneliusC, CuzzocreaS, IavicoliI, RizzarelliE, and CalabreseEJ. Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol Aspects Med, 32: 279–304, 2011.
33.
CalingasanNY, UchidaK, and GibsonGE. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem, 72: 751–756, 1999.
34.
CaoJY and DixonSJ. Mechanisms of ferroptosis. Cell Mol Life Sci, 73: 2195–2209, 2016.
35.
CheignonC, TomasM, Bonnefont-RousselotD, FallerP, HureauC, and CollinF. Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol, 14: 450–464, 2018.
36.
ChristenY.Oxidative stress and Alzheimer disease. Am J Clin Nutr, 71: 621S–629S, 2000.
37.
CobleyJN, FiorelloML, and BaileyDM. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol, 15: 490–503, 2018.
38.
ColesLD, TuitePJ, OzG, MishraUR, KarthaRV, SullivanKM, CloydJC, and TerpstraM. Repeated-dose oral N-acetylcysteine in Parkinson's disease: pharmacokinetics and effect on brain glutathione and oxidative stress. J Clin Pharmacol, 58: 158–167, 2018.
39.
ConradM, KaganVE, BayirH, PagnussatGC, HeadB, TraberMG, and StockwellBR. Regulation of lipid peroxidation and ferroptosis in diverse species. Genes Dev, 32: 602–619, 2018.
40.
CordesCM, BennettRG, SifordGL, and HamelFG. Redox regulation of insulin degradation by insulin-degrading enzyme. PLoS One, 6: e18138, 2011.
41.
CornfordEM, BraunLD, CranePD, and OldendorfWH. Blood-brain barrier restriction of peptides and the low uptake of enkephalins. Endocrinology, 103: 1297–1303, 1978.
42.
CotgreaveIA and GerdesRG. Recent trends in glutathione biochemistry—glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation?. Biochem Biophys Res Commun, 242: 1–9, 1998.
43.
CoxAG, WinterbournCC, and HamptonMB. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J, 425: 313–325, 2009.
44.
CristalliDO, ArnalN, MarraFA, de AlanizMJ, and MarraCA. Peripheral markers in neurodegenerative patients and their first-degree relatives. J Neurol Sci, 314: 48–56, 2012.
45.
CummingRC, AndonNL, HaynesPA, ParkM, FischerWH, and SchubertD. Protein disulfide bond formation in the cytoplasm during oxidative stress. J Biol Chem, 279: 21749–21758, 2004.
46.
CummingRC and SchubertD. Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J, 19: 2060–2062, 2005.
47.
DangTN, ArseneaultM, ZarkovicN, WaegG, and RamassamyC. Molecular regulations induced by acrolein in neuroblastoma SK-N-SH cells: relevance to Alzheimer's disease. J Alzheimers Dis, 21: 1197–1216, 2010.
48.
DattiloS, MancusoC, KoverechG, Di MauroP, OntarioML, PetraliaCC, PetraliaA, MaiolinoL, SerraA, CalabreseEJ, and CalabreseV. Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases. Immun Ageing, 12: 20, 2015.
49.
De BundelD, SchallierA, LoyensE, FernandoR, MiyashitaH, Van LiefferingeJ, VermoesenK, BannaiS, SatoH, MichotteY, SmoldersI, and MassieA. Loss of system x(c)- does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility. J Neurosci, 31: 5792–5803, 2011.
50.
DecK, LukomskaA, Skonieczna-ZydeckaK, JakubczykK, TarnowskiM, LubkowskaA, Baranowska-BosiackaI, StyburskiD, Skorka-MajewiczM, MaciejewskaD, and GutowskaI. Chronic exposure to fluoride affects GSH level and NOX4 expression in rat model of this element of neurotoxicity. Biomolecules, 10: 422, 2020.
51.
DesaiKM, ChangT, WangH, BanigeshA, DharA, LiuJ, UntereinerA, and WuL. Oxidative stress and aging: is methylglyoxal the hidden enemy?. Can J Physiol Pharmacol, 88: 273–284, 2010.
52.
Di DomenicoF, CeniniG, SultanaR, PerluigiM, UbertiD, MemoM, and ButterfieldDA. Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis. Neurochem Res, 34: 727–733, 2009.
53.
Diaz-HernandezJI, AlmeidaA, Delgado-EstebanM, FernandezE, and BolanosJP. Knockdown of glutamate-cysteine ligase by small hairpin RNA reveals that both catalytic and modulatory subunits are essential for the survival of primary neurons. J Biol Chem, 280: 38992–39001, 2005.
54.
DinotoL, DetureMA, and PurichDL. Structural insights into Alzheimer filament assembly pathways based on site-directed mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein. Microsc Res Tech, 67: 156–163, 2005.
55.
DixonSJ, LembergKM, LamprechtMR, SkoutaR, ZaitsevEM, GleasonCE, PatelDN, BauerAJ, CantleyAM, YangWS, MorrisonB, 3rd, and StockwellBR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 149: 1060–1072, 2012.
56.
DorszewskaJ, KowalskaM, PrendeckiM, PiekutT, KozlowskaJ, and KozubskiW. Oxidative stress factors in Parkinson's disease. Neural Regen Res, 16: 1383–1391, 2021.
57.
DringenR, PawlowskiPG, and HirrlingerJ. Peroxide detoxification by brain cells. J Neurosci Res, 79: 157–165, 2005.
58.
DringenR, PfeifferB, and HamprechtB. Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci, 19: 562–569, 1999.
59.
DuY, ZhangH, LuJ, and HolmgrenA. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose. J Biol Chem, 287: 38210–38219, 2012.
60.
EmendatoA, MilordiniG, ZaccoE, SicorelloA, Dal PiazF, GuerriniR, ThorogateR, PiconeD, and PastoreA. Glycation affects fibril formation of Abeta peptides. J Biol Chem, 293: 13100–13111, 2018.
61.
EsterbauerH, SchaurRJ, and ZollnerH. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med, 11: 81–128, 1991.
62.
FavilliF, MarracciniP, IantomasiT, and VincenziniMT. Effect of orally administered glutathione on glutathione levels in some organs of rats: role of specific transporters. Br J Nutr, 78: 293–300, 1997.
63.
FernandezA, LlacunaL, Fernandez-ChecaJC, and ColellA. Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity. J Neurosci, 29: 6394–6405, 2009.
64.
FindlayVJ, TownsendDM, MorrisTE, FraserJP, HeL, and TewKD. A novel role for human sulfiredoxin in the reversal of glutathionylation. Cancer Res, 66: 6800–6806, 2006.
65.
FlemingTH, HumpertPM, NawrothPP, and BierhausA. Reactive metabolites and AGE/RAGE-mediated cellular dysfunction affect the aging process: a mini-review. Gerontology, 57: 435–443, 2011.
66.
FrancoR and CidlowskiJA. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ, 16: 1303–1314, 2009.
67.
FratelliM, GoodwinLO, OromUA, LombardiS, TonelliR, MengozziM, and GhezziP. Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc Natl Acad Sci U S A, 102: 13998–14003, 2005.
68.
GaillardPJ, AppeldoornCC, DorlandR, van KregtenJ, MancaF, VugtsDJ, WindhorstB, van DongenGA, de VriesHE, MaussangD, and van TellingenO. Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3–101). PLoS One, 9: e82331, 2014.
69.
GaillardPJ, AppeldoornCC, RipJ, DorlandR, van der PolSM, KooijG, de VriesHE, and ReijerkerkA. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. J Control Release, 164: 364–369, 2012.
70.
GanJC and AnsariGA. Plausible mechanism of inactivation of plasma alpha 1-proteinase inhibitor by acrolein. Res Commun Chem Pathol Pharmacol, 55: 419–422, 1987.
71.
GaucherC, BoudierA, BonettiJ, ClarotI, LeroyP, and ParentM. Glutathione: antioxidant properties dedicated to nanotechnologies. Antioxidants (Basel), 7: 62, 2018.
72.
GeldenhuysW, WehrungD, GroshevA, HiraniA, and SutariyaV. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers. Pharm Dev Technol, 20: 497–506, 2015.
73.
GreethamD, VickerstaffJ, ShentonD, PerroneGG, DawesIW, and GrantCM. Thioredoxins function as deglutathionylase enzymes in the yeast Saccharomyces cerevisiae. BMC Biochem, 11: 3, 2010.
74.
GriffithOW and MulcahyRT. The enzymes of glutathione synthesis: gamma-glutamylcysteine synthetase. Adv Enzymol Relat Areas Mol Biol, 73: 209–267, xii, 1999.
GuillozetAL, WeintraubS, MashDC, and MesulamMM. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol, 60: 729–736, 2003.
77.
HaackeEM, ChengNY, HouseMJ, LiuQ, NeelavalliJ, OggRJ, KhanA, AyazM, KirschW, and ObenausA. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging, 23: 1–25, 2005.
78.
HabasA, HahnJ, WangX, and MargetaM. Neuronal activity regulates astrocytic Nrf2 signaling. Proc Natl Acad Sci U S A, 110: 18291–18296, 2013.
79.
HaddadM, PerrotteM, Landri. S, Lepage. A, Fülöp T, and Ramassamy C. Circulating and extracellular vesicles levels of N-(1-carboxymethyl)-L-lysine (CML) differentiate early to moderate Alzheimer's disease. J Alzheimers Dis, 69: 751–762, 2019.
80.
HambrightWS, FonsecaRS, ChenL, NaR, and RanQ. Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol, 12: 8–17, 2017.
81.
HanSH, HuletteC, SaundersAM, EinsteinG, Pericak-VanceM, StrittmatterWJ, RosesAD, and SchmechelDE. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp Neurol, 128: 13–26, 1994.
82.
HardingHP, ZhangY, ZengH, NovoaI, LuPD, CalfonM, SadriN, YunC, PopkoB, PaulesR, StojdlDF, BellJC, HettmannT, LeidenJM, and RonD. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell, 11: 619–633, 2003.
83.
HaselP, McKayS, QiuJ, and HardinghamGE. Selective dendritic susceptibility to bioenergetic, excitotoxic and redox perturbations in cortical neurons. Biochim Biophys Acta, 1853: 2066–2076, 2015.
84.
HirrlingerJ and DringenR. The cytosolic redox state of astrocytes: maintenance, regulation and functional implications for metabolite trafficking. Brain Res Rev, 63: 177–188, 2010.
85.
HirrlingerJ, SchulzJB, and DringenR. Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells. J Neurosci Res, 69: 318–326, 2002.
86.
HolmgrenA.Thioredoxin. Annu Rev Biochem, 54: 237–271, 1985.
87.
HoltzmanDM, BalesKR, TenkovaT, FaganAM, ParsadanianM, SartoriusLJ, MackeyB, OlneyJ, McKeelD, WozniakD, and PaulSM. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A, 97: 2892–2897, 2000.
88.
HuangYJ, JinMH, PiRB, ZhangJJ, OuyangY, ChaoXJ, ChenMH, LiuPQ, YuJC, RamassamyC, DouJ, ChenXH, JiangYM, and QinJ. Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo. Toxicol Lett, 217: 184–191, 2013.
89.
IantomasiT, FavilliF, MarracciniP, MagaldiT, BruniP, and VincenziniMT. Glutathione transport system in human small intestine epithelial cells. Biochim Biophys Acta, 1330: 274–283, 1997.
90.
InnamoratoNG, Lastres-BeckerI, and CuadradoA. Role of microglial redox balance in modulation of neuroinflammation. Curr Opin Neurol, 22: 308–314, 2009.
91.
IshigeK, SchubertD, and SagaraY. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med, 30: 433–446, 2001.
92.
IshiiT and MannGE. Redox status in mammalian cells and stem cells during culture in vitro: critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance. Redox Biol, 2: 786–794, 2014.
93.
Jimenez-BlascoD, Santofimia-CastanoP, GonzalezA, AlmeidaA, and BolanosJP. Astrocyte NMDA receptors' activity sustains neuronal survival through a Cdk5-Nrf2 pathway. Cell Death Differ, 22: 1877–1889, 2015.
94.
JinN, HarveenK, CollierT, ChangK, BrooksAES, AllisonJR, BrimbleMA, HickeyA, and BirchNP. Site-specific glycations of Aβ1–42 affect fibril formation and are neurotoxic. J Biol Chem, 294: 8806–8818, 2019.
95.
JohanssonC, LilligCH, and HolmgrenA. Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J Biol Chem, 279: 7537–7543, 2004.
96.
JonesDP.Disruption of mitochondrial redox circuitry in oxidative stress. Chem Biol Interact, 163: 38–53, 2006.
97.
JonesDP and GoYM. Redox compartmentalization and cellular stress. Diabetes Obes Metab, 12 Suppl 2: 116–125, 2010.
98.
KangY, ViswanathV, JhaN, QiaoX, MoJQ, and AndersenJK. Brain gamma-glutamyl cysteine synthetase (GCS) mRNA expression patterns correlate with regional-specific enzyme activities and glutathione levels. J Neurosci Res, 58: 436–441, 1999.
99.
KannanR, ChakrabartiR, TangD, KimKJ, and KaplowitzN. GSH transport in human cerebrovascular endothelial cells and human astrocytes: evidence for luminal localization of Na+-dependent GSH transport in HCEC. Brain Res, 852: 374–382, 2000.
100.
KannanR, KuhlenkampJF, JeandidierE, TrinhH, OokhtensM, and KaplowitzN. Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat. J Clin Invest, 85: 2009–2013, 1990.
101.
KarelsonE, BogdanovicN, GarlindA, WinbladB, ZilmerK, KullisaarT, VihalemmT, KairaneC, and ZilmerM. The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defense. Neurochem Res, 26: 353–361, 2001.
102.
KawakamiK, FujitaY, MatsudaY, AraiT, HorieK, KameyamaK, KatoT, MasunagaK, KasuyaY, TanakaM, MizutaniK, DeguchiT, and ItoM. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer. BMC Cancer, 17: 316, 2017.
103.
KehrerJP and BiswalSS. The molecular effects of acrolein. Toxicol Sci, 57: 6–15, 2000.
104.
KenslerTW, WakabayashiN, and BiswalS. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol, 47: 89–116, 2007.
105.
KhazaeiMR, Habibi-RezaeiM, KarimzadehF, Moosavi-MovahediAA, SarrafnejhadAA, SabouniF, and BakhtiM. Microglial cell death induced by glycated bovine serum albumin: nitric oxide involvement. J Biochem, 144: 197–206, 2008.
106.
KraftAD, JohnsonDA, and JohnsonJA. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci, 24: 1101–1112, 2004.
107.
KuhlaB, BoeckK, LuthHJ, SchmidtA, WeigleB, SchmitzM, OgunladeV, MunchG, and ArendtT. Age-dependent changes of glyoxalase I expression in human brain. Neurobiol Aging, 27: 815–822, 2006.
108.
KuhlaB, BoeckK, SchmidtA, OgunladeV, ArendtT, MunchG, and LuthHJ. Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiol Aging, 28: 29–41, 2007.
109.
LashLH and JonesDP. Distribution of oxidized and reduced forms of glutathione and cysteine in rat plasma. Arch Biochem Biophys, 240: 583–592, 1985.
110.
LeeM, ChoT, JantaratnotaiN, WangYT, McGeerE, and McGeerPL. Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J, 24: 2533–2545, 2010.
111.
LeeYS, LeeDH, ChoudryHA, BartlettDL, and LeeYJ. Ferroptosis-induced endoplasmic reticulum stress: cross-talk between ferroptosis and apoptosis. Mol Cancer Res, 16: 1073–1076, 2018.
112.
LewerenzJ, AtesG, MethnerA, ConradM, and MaherP. Oxytosis/ferroptosis-(re-) emerging roles for oxidative stress-dependent non-apoptotic cell death in diseases of the central nervous system. Front Neurosci, 12: 214, 2018.
113.
LiW, BusuC, CircuML, and AwTY. Glutathione in cerebral microvascular endothelial biology and pathobiology: implications for brain homeostasis. Int J Cell Biol, 2012: 434971, 2012.
114.
LiXH, LvBL, XieJZ, LiuJ, ZhouXW, and WangJZ. AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation. Neurobiol Aging, 33: 1400–1410, 2012.
115.
LiXH, XieJZ, JiangX, LvBL, ChengXS, DuLL, ZhangJY, WangJZ, and ZhouXW. Methylglyoxal induces tau hyperphosphorylation via promoting AGEs formation. Neuromolecular Med, 14: 338–348, 2012.
116.
LiangB, PengP, ChenS, LiL, ZhangM, CaoD, YangJ, LiH, GuiT, LiX, and ShenK. Characterization and proteomic analysis of ovarian cancer-derived exosomes. J Proteomics, 80: 171–182, 2013.
117.
LindqvistA, RipJ, GaillardPJ, BjorkmanS, and Hammarlund-UdenaesM. Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study. Mol Pharm, 10: 1533–1541, 2013.
118.
LiuH, WangH, ShenviS, HagenTM, and LiuRM. Glutathione metabolism during aging and in Alzheimer disease. Ann N Y Acad Sci, 1019: 346–349, 2004.
119.
LiuY, ChenZ, LiB, YaoH, ZarkaM, WelchJ, SachdevP, BridgeW, and BraidyN. Supplementation with gamma-glutamylcysteine (gamma-GC) lessens oxidative stress, brain inflammation and amyloid pathology and improves spatial memory in a murine model of AD. Neurochem Int, 144: 104931, 2021.
120.
LovellMA, XieC, and MarkesberyWR. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging, 22: 187–194, 2001.
121.
LuJ, BerndtC, and HolmgrenA. Metabolism of selenium compounds catalyzed by the mammalian selenoprotein thioredoxin reductase. Biochim Biophys Acta, 1790: 1513–1519, 2009.
122.
LuJ and HolmgrenA. The thioredoxin antioxidant system. Free Radic Biol Med, 66: 75–87, 2014.
123.
LundbergM, JohanssonC, ChandraJ, EnokssonM, JacobssonG, LjungJ, JohanssonM, and HolmgrenA. Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms. J Biol Chem, 276: 26269–26275, 2001.
124.
LushchakVI.Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids, 2012: 736837, 2012.
125.
MaQ and HeX. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev, 64: 1055–1081, 2012.
126.
MaherP.Potentiation of glutathione loss and nerve cell death by the transition metals iron and copper: implications for age-related neurodegenerative diseases. Free Radic Biol Med, 115: 92–104, 2018.
127.
MaherP, DarguschR, EhrenJL, OkadaS, SharmaK, and SchubertD. Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes. PLoS One, 6: e21226, 2011.
128.
MaiorinoM, ConradM, and UrsiniF. GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues. Antioxid Redox Signal, 29: 61–74, 2018.
129.
MandalPK, SaharanS, TripathiM, and MurariG. Brain glutathione levels—a novel biomarker for mild cognitive impairment and Alzheimer's disease. Biol Psychiatry, 78: 702–710, 2015.
MandalPK, TripathiM, and SugunanS. Brain oxidative stress: detection and mapping of anti-oxidant marker ‘Glutathione’ in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy. Biochem Biophys Res Commun, 417: 43–48, 2012.
132.
MaoX, LiZP, and TangZY. One pot synthesis of monodispersed L-glutathione stabilized gold nanoparticles for the detection of Pb2+ ions. Front Mater Sci, 5: 322–328, 2011.
133.
MariM, MoralesA, ColellA, Garcia-RuizC, and Fernandez-ChecaJC. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal, 11: 2685–2700, 2009.
134.
MarkesberyWR and LovellMA. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch Neurol, 64: 954–956, 2007.
135.
MarnettLJ, RigginsJN, and WestJD. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest, 111: 583–593, 2003.
136.
MasaldanS, BushAI, DevosD, RollandAS, and MoreauC. Striking while the iron is hot: iron metabolism and ferroptosis in neurodegeneration. Free Radic Biol Med, 133: 221–233, 2019.
137.
MattsonMP and ChengA. Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci, 29: 632–639, 2006.
138.
MaussangD, RipJ, van KregtenJ, van den HeuvelA, van der PolS, van der BoomB, ReijerkerkA, ChenL, de BoerM, GaillardP, and de VriesH. Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo. Drug Discov Today Technol, 20: 59–69, 2016.
139.
MaynardCJ, BushAI, MastersCL, CappaiR, and LiQX. Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol, 86: 147–159, 2005.
140.
McBeanGJ, AslanM, GriffithsHR, and TorraoRC. Thiol redox homeostasis in neurodegenerative disease. Redox Biol, 5: 186–194, 2015.
141.
MengQ, PengZ, ChenL, SiJ, DongZ, and XiaY. Nuclear Factor-kappaB modulates cellular glutathione and prevents oxidative stress in cancer cells. Cancer Lett, 299: 45–53, 2010.
142.
MitchellDY and PetersenDR. Metabolism of the glutathione-acrolein adduct, S-(2-aldehydo-ethyl)glutathione, by rat liver alcohol and aldehyde dehydrogenase. J Pharmacol Exp Ther, 251: 193–198, 1989.
143.
MontineKS, QuinnJF, ZhangJ, FesselJP, RobertsLJ, 2nd, MorrowJD, and MontineTJ. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem Phys Lipids, 128: 117–124, 2004.
MontineTJ, HuangDY, ValentineWM, AmarnathV, SaundersA, WeisgraberKH, GrahamDG, and StrittmatterWJ. Crosslinking of apolipoprotein E by products of lipid peroxidation. J Neuropathol Exp Neurol, 55: 202–210, 1996.
146.
MontineTJ, MontineKS, McMahanW, MarkesberyWR, QuinnJF, and MorrowJD. F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxid Redox Signal, 7: 269–275, 2005.
147.
MontineTJ, NeelyMD, QuinnJF, BealMF, MarkesberyWR, RobertsLJ, and MorrowJD. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic Biol Med, 33: 620–626, 2002.
MulcahyRT, WartmanMA, BaileyHH, and GippJJ. Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J Biol Chem, 272: 7445–7454, 1997.
150.
MurphyTH, MiyamotoM, SastreA, SchnaarRL, and CoyleJT. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron, 2: 1547–1558, 1989.
151.
NamDT, ArseneaultM, MurthyV, and RamassamyC. Potential role of acrolein in neurodegeneration and in Alzheimer's disease. Curr Mol Pharmacol, 3: 66–78, 2010.
152.
NamDT, ArseneaultM, and RamassamyC. Regulation of redox-sensitive signaling pathways in rat primary astrocytes following acrolein exposure. J Alzheimers Dis, 25: 263–277, 2011.
153.
NewmanSF, SultanaR, PerluigiM, CocciaR, CaiJ, PierceWM, KleinJB, TurnerDM, and ButterfieldDA. An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach. J Neurosci Res, 85: 1506–1514, 2007.
154.
NosratiH, TarantashM, BochaniS, CharmiJ, BagheriZ, FridoniM, AbdollahifarM-A, DavaranS, DanafarH, and Kheiri ManjiliH. Glutathione (GSH) peptide conjugated magnetic nanoparticles as blood–brain barrier shuttle for MRI-monitored brain delivery of paclitaxel. ACS Biomater Sci Eng, 5: 1677–1685, 2019.
155.
OkadaM, FukuyamaK, KawanoY, ShiroyamaT, and UedaY. Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc-. Pharmacol Res Perspect, 7: e00457, 2019.
156.
Ottestad-HansenS, HuQX, Follin-ArbeletVV, BenteaE, SatoH, MassieA, ZhouY, and DanboltNC. The cystine-glutamate exchanger (xCT, Slc7a11) is expressed in significant concentrations in a subpopulation of astrocytes in the mouse brain. Glia, 66: 951–970, 2018.
157.
OwenJB and ButterfieldDA. Measurement of oxidized/reduced glutathione ratio. Methods Mol Biol, 648: 269–277, 2010.
158.
PakaGD and RamassamyC. Optimization of curcumin-loaded PEG-PLGA nanoparticles by GSH functionalization: investigation of the internalization pathway in neuronal cells. Mol Pharm, 14: 93–106, 2017.
PastoreA, TozziG, GaetaLM, BertiniE, SerafiniV, Di CesareS, BonettoV, CasoniF, CarrozzoR, FedericiG, and PiemonteF. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. J Biol Chem, 278: 42588–42595, 2003.
161.
PeltoniemiMJ, KaralaAR, JurvansuuJK, KinnulaVL, and RuddockLW. Insights into deglutathionylation reactions. Different intermediates in the glutaredoxin and protein disulfide isomerase catalyzed reactions are defined by the gamma-linkage present in glutathione. J Biol Chem, 281: 33107–33114, 2006.
162.
Pena-BautistaC, VentoM, BaqueroM, and Chafer-PericasC. Lipid peroxidation in neurodegeneration. Clin Chim Acta, 497: 178–188, 2019.
163.
PerrotteM, Le PageA, FournetM, Le SayecM, RassartE, FulopT, and RamassamyC. Blood-based redox-signature and their association to the cognitive scores in MCI and Alzheimer's disease patients. Free Radic Biol Med, 130: 499–511, 2019.
164.
PerryTL, YongVW, BergeronC, HansenS, and JonesK. Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease. Ann Neurol, 21: 331–336, 1987.
165.
PhillipsSA and ThornalleyPJ. The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem, 212: 101–105, 1993.
166.
Pienimaeki-RoemerA, KuhlmannK, BottcherA, KonovalovaT, BlackA, OrsoE, LiebischG, AhrensM, EisenacherM, MeyerHE, and SchmitzG. Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets. Transfusion, 55: 507–521, 2015.
167.
PocernichCB and ButterfieldDA. Elevation of glutathione as a therapeutic strategy in Alzheimer disease. Biochim Biophys Acta, 1822: 625–630, 2012.
168.
PriorJO.Diabetes and vascular (18)f-fluorodeoxyglucose positron emission tomography uptake: another step toward understanding inflammation in atherosclerosis. J Am Coll Cardiol, 59: 2089–2090, 2012.
169.
RamanaKV, DixitBL, SrivastavaS, BalendiranGK, SrivastavaSK, and BhatnagarA. Selective recognition of glutathiolated aldehydes by aldose reductase. Biochemistry, 39: 12172–12180, 2000.
170.
RamassamyC, AverillD, BeffertU, BastianettoS, TherouxL, Lussier-CacanS, CohnJS, ChristenY, DavignonJ, QuirionR, and PoirierJ. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic Biol Med, 27: 544–553, 1999.
171.
RamassamyC, AverillD, BeffertU, TherouxL, Lussier-CacanS, CohnJS, ChristenY, SchoofsA, DavignonJ, and PoirierJ. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol Dis, 7: 23–37, 2000.
172.
RanaAK and SinghD. Targeting glycogen synthase kinase-3 for oxidative stress and neuroinflammation: opportunities, challenges and future directions for cerebral stroke management. Neuropharmacology, 139: 124–136, 2018.
173.
ReedTT, PierceWM, MarkesberyWR, and ButterfieldDA. Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD. Brain Res, 1274: 66–76, 2009.
174.
RichieJPJr., NichenametlaS, NeidigW, CalcagnottoA, HaleyJS, SchellTD, and MuscatJE.Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr, 54: 251–263, 2015.
175.
RipJ, ChenL, HartmanR, van den HeuvelA, ReijerkerkA, van KregtenJ, van der BoomB, AppeldoornC, de BoerM, MaussangD, de LangeEC, and GaillardPJ. Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats. J Drug Target, 22: 460–467, 2014.
176.
RistowM.Unraveling the truth about antioxidants: mitohormesis explains ROS-induced health benefits. Nat Med, 20: 709–711, 2014.
177.
RotmanM, WellingMM, BunschotenA, de BackerME, RipJ, NabuursRJ, GaillardPJ, van BuchemMA, van der MaarelSM, and van der WeerdL. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease. J Control Release, 203: 40–50, 2015.
178.
SasakiH, SatoH, Kuriyama-MatsumuraK, SatoK, MaebaraK, WangH, TambaM, ItohK, YamamotoM, and BannaiS. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem, 277: 44765–44771, 2002.
179.
SatoH, NomuraS, MaebaraK, SatoK, TambaM, and BannaiS. Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation. Biochem Biophys Res Commun, 325: 109–116, 2004.
180.
SatoH, TambaM, OkunoS, SatoK, Keino-MasuK, MasuM, and BannaiS. Distribution of cystine/glutamate exchange transporter, system x(c)-, in the mouse brain. J Neurosci, 22: 8028–8033, 2002.
181.
SchaferFQ and BuettnerGR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med, 30: 1191–1212, 2001.
182.
ScheffSW, AnsariMA, and MufsonEJ. Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology. Neurobiol Aging, 42: 1–12, 2016.
183.
SchmittB, VicenziM, GarrelC, and DenisFM. Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: a comparative crossover study. Redox Biol, 6: 198–205, 2015.
184.
SchragM, MuellerC, ZabelM, CroftonA, KirschWM, GhribiO, SquittiR, and PerryG. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis. Neurobiol Dis, 59: 100–110, 2013.
185.
SenCK and PackerL. Antioxidant and redox regulation of gene transcription. FASEB J, 10: 709–720, 1996.
186.
Serrano-PozoA, DasS, and HymanBT. APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol, 20: 68–80, 2021.
ShihAY, JohnsonDA, WongG, KraftAD, JiangL, ErbH, JohnsonJA, and MurphyTH. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci, 23: 3394–3406, 2003.
189.
ShuklaD, MandalPK, TripathiM, VishwakarmaG, MishraR, and SandalK. Quantitation of in vivo brain glutathione conformers in cingulate cortex among age-matched control, MCI, and AD patients using MEGA-PRESS. Hum Brain Mapp, 41: 194–217, 2020.
190.
SinghM, DangTN, ArseneaultM, and RamassamyC. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein. J Alzheimers Dis, 21: 741–756, 2010.
191.
SinghM, MurthyV, and RamassamyC. Modulation of hydrogen peroxide and acrolein-induced oxidative stress, mitochondrial dysfunctions and redox regulated pathways by the bacopa monniera extract: potential implication in Alzheimer's disease. J Alzheimers Dis, 21: 229–247, 2010.
192.
SinghN, HaldarS, TripathiAK, HorbackK, WongJ, SharmaD, BeserraA, SudaS, AnbalaganC, DevS, MukhopadhyayCK, and SinghA. Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal, 20: 1324–1363, 2014.
193.
SinhaR, SinhaI, CalcagnottoA, TrushinN, HaleyJS, SchellTD, and RichieJPJr. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr, 72: 105–111, 2018.
194.
SmithCV, JonesDP, GuenthnerTM, LashLH, and LauterburgBH. Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicol Appl Pharmacol, 140: 1–12, 1996.
195.
SonnenJA, BreitnerJC, LovellMA, MarkesberyWR, QuinnJF, and MontineTJ. Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radic Biol Med, 45: 219–230, 2008.
196.
SparacoM, GaetaLM, TozziG, BertiniE, PastoreA, SimonatiA, SantorelliFM, and PiemonteF. Protein glutathionylation in human central nervous system: potential role in redox regulation of neuronal defense against free radicals. J Neurosci Res, 83: 256–263, 2006.
197.
StarkovAA, AndreyevAY, ZhangSF, StarkovaNN, KorneevaM, SyromyatnikovM, and PopovVN. Scavenging of H2O2 by mouse brain mitochondria. J Bioenerg Biomembr, 46: 471–477, 2014.
SubbaraoKV, RichardsonJS, and AngLC. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem, 55: 342–345, 1990.
200.
SunX, ShihAY, JohannssenHC, ErbH, LiP, and MurphyTH. Two-photon imaging of glutathione levels in intact brain indicates enhanced redox buffering in developing neurons and cells at the cerebrospinal fluid and blood-brain interface. J Biol Chem, 281: 17420–17431, 2006.
201.
TaylorAR, RobinsonMB, GifondorwaDJ, TytellM, and MilliganCE. Regulation of heat shock protein 70 release in astrocytes: role of signaling kinases. Dev Neurobiol, 67: 1815–1829, 2007.
202.
TaylorS, WheelerLC, TaylorJR, and GriffinHC. Nutrition: an issue of concern for children with disabilities. Nurse Pract, 21: 17–18, 20, 1996.
203.
TebayLE, RobertsonH, DurantST, VitaleSR, PenningTM, Dinkova-KostovaAT, and HayesJD. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med, 88: 108–146, 2015.
204.
TeshigawaraM, MatsumotoS, TsuboiS, and OhmoriS. Changes in levels of glutathione and related compounds and activities of glutathione-related enzymes during rat liver regeneration. Res Exp Med (Berl), 195: 55–60, 1995.
205.
ThornalleyPJ.Glyoxalase I—structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans, 31: 1343–1348, 2003.
206.
TroyanoA, SanchoP, FernandezC, de BlasE, BernardiP, and AllerP. The selection between apoptosis and necrosis is differentially regulated in hydrogen peroxide-treated and glutathione-depleted human promonocytic cells. Cell Death Differ, 10: 889–898, 2003.
207.
TsouHH, HsuWC, FuhJL, ChenSP, LiuTY, and WangHT. Alterations in acrolein metabolism contribute to Alzheimer's disease. J Alzheimers Dis, 61: 571–580, 2018.
208.
UylingsHB and de BrabanderJM. Neuronal changes in normal human aging and Alzheimer's disease. Brain Cogn, 49: 268–276, 2002.
209.
van TellingenO, BrandsmaD, BoogerdW, AppeldoornC, MancaF, RipJ, DorlandR, van KregtenJ, and GaillardP.GSH-conjugation improves efficacy of doxil against intracranial xenografts. Neurooncology, 12: iii34, 2010.
210.
VargasMR and JohnsonJA. The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev Mol Med, 11: e17, 2009.
211.
VeluCS, NitureSK, DoneanuCE, PattabiramanN, and SrivenugopalKS. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry, 46: 7765–7780, 2007.
212.
VerkhratskyA, MatteoliM, ParpuraV, MothetJP, and ZorecR. Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion. EMBO J, 35: 239–257, 2016.
213.
VoehringerDW.BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. Free Radic Biol Med, 27: 945–950, 1999.
214.
WangP, HuangR, LuS, XiaW, CaiR, SunH, and WangS. RAGE and AGEs in mild cognitive impairment of diabetic patients: a cross-sectional study. PLoS One, 11: e0145521, 2016.
215.
WilliamsTI, LynnBC, MarkesberyWR, and LovellMA. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging, 27: 1094–1099, 2006.
216.
YaffeK, LindquistK, SchwartzAV, VitartasC, VittinghoffE, SatterfieldS, SimonsickEM, LaunerL, RosanoC, CauleyJA, and HarrisT. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology, 77: 1351–1356, 2011.
217.
YeP, MimuraJ, OkadaT, SatoH, LiuT, MaruyamaA, OhyamaC, and ItohK. Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition. Mol Cell Biol, 34: 3421–3434, 2014.
218.
YinQQ, DongCF, DongSQ, DongXL, HongY, HouXY, LuoDZ, PeiJJ, and LiuXP. AGEs induce cell death via oxidative and endoplasmic reticulum stresses in both human SH-SY5Y neuroblastoma cells and rat cortical neurons. Cell Mol Neurobiol, 32: 1299–1309, 2012.
219.
YingW.NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal, 10: 179–206, 2008.
220.
ZarkaMH and BridgeWJ. Oral administration of gamma-glutamylcysteine increases intracellular glutathione levels above homeostasis in a randomised human trial pilot study. Redox Biol, 11: 631–636, 2017.
221.
ZeevalkGD, BernardLP, and GuilfordFT. Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells. Neurochem Res, 35: 1575–1587, 2010.
222.
ZhangC, KuoCC, ChiuAW, and FengJ. Prediction of S-glutathionylated proteins progression in Alzheimer's transgenic mouse model using principle component analysis. J Alzheimers Dis, 30: 919–934, 2012.
